5 insiders reported 5 Form 4 transactions for Calidi Biotherapeutics, Inc. (CLDI) over the past 18 months (most recent 2025-12-16). Recent activity: Camaisa Allan (Director) Sell 850 shares, Jackson Andrew C. (Chief Financial Officer) Buy 2,500 shares, Schoeneck James A (Director) Buy 75,000 shares, Leftwich Scott (Director) Buy 125,000 shares, Poma Eric E (Chief Executive Officer) Buy 25,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-16 | Camaisa Allan | Director | Sell | 850 | $1,241 |
| 2025-08-25 | Jackson Andrew C. | Chief Financial Officer | Buy | 2,500 | $5,000 |
| 2025-08-25 | Schoeneck James A | Director | Buy | 75,000 | $150,000 |
| 2025-08-25 | Leftwich Scott | Director | Buy | 125,000 | $250,000 |
| 2025-08-25 | Poma Eric E | Chief Executive Officer | Buy | 25,000 | $50,000 |
Source: SEC Form 4 filings · as of 2025-12-16